These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 208809)

  • 1. Impaired production of T-lymphocyte mitogens in pediatric malignant disease.
    Leikin SL; Esber E; Oppenheim J
    Clin Immunol Immunopathol; 1978 Jul; 10(3):251-7. PubMed ID: 208809
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lymphocyte transformation and immunoglobulins in children with acute lymphatic leukemias and malignant tumors].
    Pappas A; Wahlen W; Kausch O; Scheurlen PG; Mayer JB
    Verh Dtsch Ges Inn Med; 1973; 79():429-32. PubMed ID: 4364106
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relationship between the populations of lymphoid cells in certain lymphoproliferative diseases].
    Kisliak NS; Izotova TA; Sokolov PP
    Pediatriia; 1975 Aug; (8):3-10. PubMed ID: 1081676
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Rosette stimulation by plant mitogens.
    Gergely P; Szegedi G; Szabó G; Fedete B; Petrányi G
    Lancet; 1973 Oct; 2(7834):914. PubMed ID: 4126956
    [No Abstract]   [Full Text] [Related]  

  • 5. Impaired immunoresponsiveness in tumor patients.
    Harris J; Copeland D
    Ann N Y Acad Sci; 1974; 230():56-85. PubMed ID: 4595955
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunosuppression: a paraneoplastic syndrome].
    Nagel GA
    Schweiz Med Wochenschr; 1971 Apr; 101(13):470-4. PubMed ID: 5283773
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro activation of lymphocytes from patients with malignant diseases. I. Kinetics and differences in magnitude of response.
    Benezra D; Hochman A
    Isr J Med Sci; 1971 Apr; 7(4):553-60. PubMed ID: 5281061
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro characterization of T and B lymphocytes in chronic lymphatic leukemia and Hodgkin's disease.
    Tursi A; Ferrannini A; Losito G
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:306. PubMed ID: 4604590
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunity disorders in malignant lymphomas].
    Stefanović S; Spuzić I; Ristić M; Pendić S; Ercegovac V
    Srp Arh Celok Lek; 1977; 105(3-4):245-52. PubMed ID: 929326
    [No Abstract]   [Full Text] [Related]  

  • 10. An overview of cancer immunology.
    Ritts RE; Neel HB
    Mayo Clin Proc; 1974 Feb; 49(2):118-31. PubMed ID: 4591299
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune deficiency states associated with malignant disease in man.
    Harris J; Bagai RC
    Med Clin North Am; 1972 Mar; 56(2):501-14. PubMed ID: 4623010
    [No Abstract]   [Full Text] [Related]  

  • 12. Thoracic-duct and blood lymphocytes in cancer.
    Benninghoff DL; Girardet RE; Porteous DD
    Lancet; 1973 Aug; 2(7823):264-5. PubMed ID: 4124456
    [No Abstract]   [Full Text] [Related]  

  • 13. Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: the role of suppressor cells.
    Zembala M; Mytar B; Popiela T; Asherson GL
    Int J Cancer; 1977 May; 19(5):605-13. PubMed ID: 301122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressor cells in neoplastic disease.
    Broder S; Muul L; Waldmann TA
    J Natl Cancer Inst; 1978 Jul; 61(1):5-11. PubMed ID: 353295
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lymphocyte blastogenesis in vitro in leukemias and lymphomas of childhood].
    Fabris C; De Sanctis C; Ponzone A
    Minerva Pediatr; 1971 Feb; 23(5):194-8. PubMed ID: 5280413
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lymphocyte markers in acute leukemia in childhood].
    Corona F; Varin E; Pietrogrande MC; Carnelli V; Bardare
    Minerva Pediatr; 1976 Dec; 28(39):2419-24. PubMed ID: 796656
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences in the formation of normal T lymphocyte colonies by peripheral blood cells from patients with chronic lymphocytic leukemia and Hodgkin's disease.
    Douer D; Sachs L
    Clin Exp Immunol; 1979 Dec; 38(3):514-22. PubMed ID: 317033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of thymosin on T-lymphocyte rosette formation in Nigerian patients with different types of cancer.
    Olusi SO; Oluwole SF; Odesanmi WO
    Afr J Med Med Sci; 1984; 13(3-4):103-9. PubMed ID: 6099969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invited discussion: relationship of titers of Epstein-Barr virus to cell-mediated immunity in patients with Hodgkin's disease.
    Levine PH; Reisher JI
    Natl Cancer Inst Monogr; 1973 May; 36():85-7. PubMed ID: 4355354
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of phytohemagglutinins in oncology].
    Lutsik MD
    Vopr Onkol; 1975; 21(10):103-11. PubMed ID: 1103467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.